UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 8-K

                             CURRENT REPORT PURSUANT
                          TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

         Date of report (Date of earliest event reported): August 22, 2005

                                  METLIFE, INC.
--------------------------------------------------------------------------------
        (Exact Name of Registrant as Specified in Its Charter)

         Delaware                  1-15787                     13-4075851
--------------------------------------------------------------------------------
(State or Other Jurisdiction      (Commission                  (IRS Employer
      of Incorporation)           File Number)               Identification No.)

 200 Park Avenue, New York, New York                    10166-0188
--------------------------------------------------------------------------------
(Address of Principal Executive Offices)                (Zip Code)

                                  212-578-2211
--------------------------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

                                       N/A
--------------------------------------------------------------------------------
        (Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

    [ ]   Written communications pursuant to Rule 425 under the Securities Act
          (17 CFR 230.425)

    [ ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
          CFR 240.14a-12)

    [ ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the
          Exchange Act (17 CFR 240.14d-2(b))

    [ ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the
          Exchange Act (17 CFR 240.13e-4(c))



ITEM 7.01  REGULATION FD DISCLOSURE.

     On August 22, 2005, MetLife, Inc. (the "Company") issued a press release 
announcing the declaration of dividends of $0.286569 per share on the Company's 
floating rate non-cumulative preferred stock, Series A and $0.4017361 per share 
on the Company's 6.50% non-cumulative preferred stock, Series B. A copy of the 
press release is attached hereto as Exhibit 99.1 and is incorporated herein by 
reference.

     The information in this report is being furnished, not filed, under 
Item 7.01 of Form 8-K.   

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

   (c)          Exhibits.

        99.1    Press release of MetLife, Inc., dated August 22, 2005, 
                announcing the declaration of dividends on its floating rate 
                non-cumulative preferred stock, Series A and its 6.50% non-
                cumulative preferred stock, Series B.



                                   SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                 METLIFE, INC.

                                 By: /s/ Gwenn L. Carr
                                     -------------------------------------------
                                     Name:  Gwenn L. Carr
                                     Title: Senior Vice-President and Secretary

Date: August 26, 2005




                                  EXHIBIT INDEX

 EXHIBIT
 NUMBER                                    EXHIBIT
--------                                   -------

  99.1         Press release of MetLife, Inc., dated August 22, 2005, announcing
               the declaration of dividends on its floating rate non-cumulative
               preferred stock, Series A and its 6.50% non-cumulative preferred
               stock, Series B.